Jupiter Life Line Hospitals Ltd.

•

jupiterhospital.comBSE: 543980NSE: JLHL

Market Cap₹ 9,197 Cr.

Current Price

High / Low₹ 340 / 236

Stock P/E49.0

Book Value₹ 48

Price to Book5.40

Dividend Yield0.07 %

ROCE15.7 %

ROE13.4 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has consistently been profitable over the last 5 years
Company has delivered good sales growth of 25.3% CAGR over last 5 years
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.15x)
Working capital cycle has improved - days down from 150 to 112
Company comfortably covers its interest (9.0x coverage)
Company has a consistent dividend-paying track record

CONS

Receivables are growing faster than sales - a possible quality concern
Free cash flow has been persistently negative
Total debt has risen sharply - up 56.1% year on year
Equity base is being diluted - shares outstanding up 16.0%
Stock is trading at 5.4x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services

Part ofNIFTY MICROCAP250 NIFTY TOTAL MKT

S.No.	Name
1.	APOLLOHOSP	8875.00	61.07	127608.88	0.23	610.40	38.41	7043.50	20.56	21.73	15.70
2.	MAXHEALTH	1039.00	69.41	101126.94	0.19	322.96	4.87	2366.17	16.70	14.97	25.29
3.	MANIPALHOS	733.10	108.07	96430.30	0.00	2434.30	—	30906.30	—	13.93	23.83
4.	FORTIS	901.80	64.97	68082.13	0.11	272.80	2.26	2545.03	17.46	14.07	21.28
5.	ASTERDM	766.70	209.71	66831.13	0.00	29.28	-68.70	1310.68	21.60	11.26	19.53
6.	MEDANTA	1459.55	70.56	39243.18	0.03	157.25	-1.09	1304.05	26.50	19.38	21.99
7.	NH	1909.10	47.80	39014.52	0.24	207.27	5.37	2683.63	78.05	16.20	17.43
8.	KIMS	772.75	158.86	32456.00	0.00	37.40	-56.00	1179.50	35.33	11.51	19.03
9.	LALPATHLAB	1916.70	59.37	32171.58	1.07	1705.00	1172.39	7977.00	1090.95	29.56	31.03
10.	AGARWALEYE	505.05	107.92	16011.41	0.00	55.02	44.56	614.02	25.97	16.14	27.75
11.	VIJAYA	1498.50	82.32	15434.21	0.13	53.10	37.61	230.98	22.83	30.28	42.66
12.	JLHL	280.55	49.02	9197.27	0.07	375.12	-14.50	4109.83	18.23	15.70	19.29

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	2,432	2,632	2,726	2,905	2,871	3,226	3,206	3,267	3,476	3,936	3,654	3,878	4,110
	2,131	2,250	2,224	2,395	2,354	2,631	2,624	2,717	2,990	3,307	3,112	3,309	3,710
Operating Profit	301	382	502	510	518	595	583	551	487	629	542	569	400
OPM %	12.38%	14.51%	18.41%	17.54%	18.03%	18.44%	18.17%	16.85%	14.00%	15.99%	14.83%	14.67%	9.72%
	64	47	82	67	84	94	83	70	129	113	155	76	106
Interest	122	122	10	9	11	11	28	56	83	78	75	90	129
Depreciation	107	106	106	104	110	144	140	176	212	215	217	233	264
Profit before Tax	338	414	581	622	601	689	666	621	615	742	569	676	506
Tax %	-59.94%	18.59%	24.82%	27.23%	25.84%	25.25%	21.10%	27.73%	28.70%	22.56%	25.32%	25.59%	25.80%
Net Profit	540	337	437	453	446	515	525	449	439	575	425	503	375
	9.93	5.67	6.56	6.49	6.80	7.86	8.01	6.84	6.69	8.75	6.49	7.66	5.72

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	463	486	733	893	1,073	1,302	1,500	15,578
	380	419	580	691	831	1,002	1,158	13,438
Operating Profit	83	67	153	201	242	300	341	2,140
OPM %	17.84%	13.81%	20.92%	22.56%	22.55%	23.04%	22.76%	13.74%
	2	4	4	8	22	28	39	450
Interest	26	39	44	42	26	11	33	373
Depreciation	26	31	36	39	42	57	88	929
Profit before Tax	33	2	77	129	195	261	260	2,492
Tax %	9.90%	247.72%	33.70%	43.36%	9.62%	25.67%	25.44%	24.67%
Net Profit	30	-2	51	73	177	194	194	1,878
EPS	5.83	-0.45	10.05	12.90	27.13	29.47	29.59	—
Dividend Payout %	0.00%	0.00%	9.95%	7.75%	3.69%	3.39%	3.38%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 25%
3 Years:: 19%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 39%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: -4%

RETURN ON EQUITY

10 Years:: —
5 Years:: 19%
3 Years:: 17%
Last Year:: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	51	51	51	57	66	66	66
Minority Interest	0	7	-5	-2	-0	0	0
	186	188	241	309	1,103	1,291	1,479
	263	413	488	469	0	385	566
Trade Payables	59	59	61	71	62	69	96
	44	70	73	82	50	107	157
Total Liabilities	603	789	909	986	1,281	1,917	2,363
	435	630	684	720	718	978	1,384
Capital Work in Progress	11	26	27	29	74	185	129
	2	7	3	2	17	507	486
	14	13	15	19	21	26	38
	0	0	0	0	57	43	76
Cash & Bank	7	19	103	134	301	95	58
	135	93	77	82	93	82	192
Total Assets	603	789	909	986	1,281	1,917	2,363

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	89	133	146	150	115	267	268
Cash from Investing	-43	-296	-85	-104	-246	-497	-442
Cash from Financing	-32	185	33	18	128	297	136
	-1	12	85	31	-3	66	-38

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91	40.91
	6.06	8.84	10.04	10.04	9.77	9.06	8.48	8.48	9.37
	13.85	13.46	12.33	12.22	12.40	13.55	14.02	13.59	13.09
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	39.17	36.79	36.72	36.84	36.92	36.50	36.59	37.02	36.62

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-07

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Jupiter Life Line Hospitals Limited has informed the Exchange about Transcript

2026-08-03

Copy of Newspaper Publication

2026-08-03 - Jupiter Life Line Hospitals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-03

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-03 - Jupiter Life Line Hospitals Limited has informed the Exchange about Link of Recording

2026-07-31

General Updates

2026-07-31 - Intimation under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements Regulations), 2015 ( Listing Regulation )

2026-07-31

Investor Presentation

2026-07-31 - Jupiter Life Line Hospitals Limited has informed the Exchange about Investor Presentation

2026-07-31

Adoption of new line(s) of business

2026-07-31 - Jupiter Life Line Hospitals Limited has informed the Exchange about Adoption of new line(s) of business

2026-07-31

Outcome of Board Meeting

2026-07-31 - Outcome of Board Meeting dated July 31, 2026

2026-07-31

Appointment

2026-07-31 - Jupiter Life Line Hospitals Limited has informed the Exchange regarding Appointment of Mr. Harshad Purani as Chief Financial Officer of the company w.e.f. July 31, 2026.

2026-07-27

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-27 - Jupiter Life Line Hospitals Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for JLHL

Loading news…

🤖

AI Stock Analyst

Jupiter Life Line Hospitals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account